Browse > Article
http://dx.doi.org/10.5090/kjtcs.2020.53.4.191

Chyle Leakage after Esophageal Cancer Surgery  

Yang, Young Ho (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine)
Park, Seong Yong (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine)
Kim, Dae Joon (Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine)
Publication Information
Journal of Chest Surgery / v.53, no.4, 2020 , pp. 191-199 More about this Journal
Abstract
Surgeons recommend dissecting lymph nodes in the thorax, abdomen, and neck during surgery for esophageal cancer because of the possibility of metastasis to the lymph nodes in those areas through the lymphatic plexus of the esophageal submucosal layer. Extensive lymph node dissection is essential for accurate staging and is thought to improve survival. However, it can result in several complications, including chyle leakage, which refers to continuous lymphatic fluid leakage and can occur in the thorax, abdomen, and neck. Malnutrition, fluid imbalance, and immune compromise may result from chyle leakage, which can be potentially life-threatening if it persists. Therefore, various treatment methods, including conservative treatment, pharmacological treatment such as octreotide infusion, and interventions such as thoracic duct embolization and surgical thoracic duct ligation, have been applied. In this article, the risk factors, diagnosis, and treatment methods of chyle leakage after esophagectomy are reviewed.
Keywords
Chyle leakage; Esophageal neoplasms; Esophagectomy; Chylothorax; Chyloperitoneum;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Weijs TJ, Ruurda JP, Broekhuizen ME, Bracco Gartner TCL, van Hillegersberg R. Outcome of a step-up treatment strategy for chyle leakage after esophagectomy. Ann Thorac Surg 2017;104:477-84.   DOI
2 Chen S, Zhao Y, Chen H. Risk factors of chylothorax after esophagectomy. J Thorac Dis 2019;11:1749-52.   DOI
3 Gupta R, Singh H, Kalia S, Gupta R, Singh R, Verma GR. Chylothorax after esophagectomy for esophageal cancer: risk factors and management. Indian J Gastroenterol 2015;34:240-4.   DOI
4 Gronnier C, Trechot B, Duhamel A, et al. Impact of neoadjuvant chemoradiotherapy on postoperative outcomes after esophageal cancer resection: results of a European multicenter study. Ann Surg 2014;260:764-70.   DOI
5 Berger AC, Scott WJ, Freedman G, et al. Morbidity and mortality are not increased after induction chemoradiotherapy followed by esophagectomy in patients with esophageal cancer. Semin Oncol 2005;32:S16-20.
6 Miao L, Zhang Y, Hu H, et al. Incidence and management of chylothorax after esophagectomy. Thorac Cancer 2015;6:354-8.   DOI
7 Ohkura Y, Ueno M, Shindoh J, Iizuka T, Ka H, Udagawa H. Risk factors for postoperative chylothorax after radical subtotal esophagectomy. Ann Surg Oncol 2018;25:2739-46.   DOI
8 Lin Y, Li Z, Li G, et al. Selective en masse ligation of the thoracic duct to prevent chyle leak after esophagectomy. Ann Thorac Surg 2017;103:1802-7.   DOI
9 Roh JL, Yoon YH, Park CI. Chyle leakage in patients undergoing thyroidectomy plus central neck dissection for differentiated papillary thyroid carcinoma. Ann Surg Oncol 2008;15:2576-80.   DOI
10 Lei Y, Feng Y, Zeng B, et al. Effect of prophylactic thoracic duct ligation in reducing the incidence of postoperative chylothorax during esophagectomy: a systematic review and meta-analysis. Thorac Cardiovasc Surg 2018;66:370-5.   DOI
11 Campisi CC, Boccardo F, Piazza C, Campisi C. Evolution of chylous fistula management after neck dissection. Curr Opin Otolaryngol Head Neck Surg 2013;21:150-6.   DOI
12 Orgill DP, Bayer LR. Update on negative-pressure wound therapy. Plast Reconstr Surg 2011;127 Suppl 1:105S-115S.   DOI
13 Kirse DJ, Suen JY, Stern SJ. Phrenic nerve paralysis after doxycycline sclerotherapy for chylous fistula. Otolaryngol Head Neck Surg 1997;116:680-3.   DOI
14 Kadota H, Kakiuchi Y, Yoshida T. Management of chylous fistula after neck dissection using negative-pressure wound therapy: a preliminary report. Laryngoscope 2012;122:997-9.   DOI
15 Dorneden A, Olson G, Boyd N. Negative pressure wound therapy (Wound VAC) in the treatment of chylous fistula after neck dissection. Ann Otol Rhinol Laryngol 2019;128:569-74.   DOI
16 Delaney SW, Shi H, Shokrani A, Sinha UK. Management of chyle leak after head and neck surgery: review of current treatment strategies. Int J Otolaryngol 2017;2017:8362874.
17 Benedix F, Schulz HU, Scheidbach H, Lippert H, Meyer F. Successful conservative treatment of chylothorax following oesophagectomy: a clinical algorithm. S Afr J Surg 2010;48:86-8.
18 Knochel JP. Complications of total parenteral nutrition. Kidney Int 1985;27:489-96.   DOI
19 Nair SK, Petko M, Hayward MP. Aetiology and management of chylothorax in adults. Eur J Cardiothorac Surg 2007;32:362-9.   DOI
20 Brazeau P, Vale W, Burgus R, et al. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973;179:77-9.   DOI
21 Rimensberger PC, Muller-Schenker B, Kalangos A, Beghetti M. Treatment of a persistent postoperative chylothorax with somatostatin. Ann Thorac Surg 1998;66:253-4.   DOI
22 Jiang H, Deng XF, Duan CM, et al. Somatostatin receptors SSTR2 and SSTR5 are expressed in the human thoracic duct. Lymphology 2011;44:21-8.
23 Swanson MS, Hudson RL, Bhandari N, Sinha UK, Maceri DR, Kokot N. Use of octreotide for the management of chyle fistula following neck dissection. JAMA Otolaryngol Head Neck Surg 2015;141:723-7.   DOI
24 Touska P, Constantinides VA, Palazzo FF. A rare complication: lymphocele following a re-operative right thyroid lobectomy for multinodular goitre. BMJ Case Rep 2012;2012:bcr0220125747.
25 Mason PF, Ragoowansi RH, Thorpe JA. Post-thoracotomy chylothorax: a cure in the abdomen? Eur J Cardiothorac Surg 1997;11:567-70.   DOI
26 Miller JI Jr. Diagnosis and management of chylothorax. Chest Surg Clin N Am 1996;6:139-48.
27 Selle JG, Snyder WH 3rd, Schreiber JT. Chylothorax: indications for surgery. Ann Surg 1973;177:245-9.   DOI
28 Bailey SH, Bull DA, Harpole DH, et al. Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg 2003;75:217-22.   DOI
29 Guillem P, Billeret V, Houcke ML, Triboulet JP. Successful management of post-esophagectomy chylothorax/chyloperitoneum by etilefrine. Dis Esophagus 1999;12:155-6.   DOI
30 Belloso A, Saravanan K, de Carpentier J. The community management of chylous fistula using a pancreatic lipase inhibitor (orlistat). Laryngoscope 2006;116:1934-5.   DOI
31 Toliyat M, Singh K, Sibley RC, Chamarthy M, Kalva SP, Pillai AK. Interventional radiology in the management of thoracic duct injuries: anatomy, techniques and results. Clin Imaging 2017;42:183-92.   DOI
32 Shimizu K, Yoshida J, Nishimura M, Takamochi K, Nakahara R, Nagai K. Treatment strategy for chylothorax after pulmonary resection and lymph node dissection for lung cancer. J Thorac Cardiovasc Surg 2002;124:499-502.   DOI
33 Wurnig PN, Hollaus PH, Ohtsuka T, Flege JB, Wolf RK. Thoracoscopic direct clipping of the thoracic duct for chylopericardium and chylothorax. Ann Thorac Surg 2000;70:1662-5.   DOI
34 Itkin M, Kucharczuk JC, Kwak A, Trerotola SO, Kaiser LR. Nonoperative thoracic duct embolization for traumatic thoracic duct leak: experience in 109 patients. J Thorac Cardiovasc Surg 2010;139:584-89.   DOI
35 Laslett D, Trerotola SO, Itkin M. Delayed complications following technically successful thoracic duct embolization. J Vasc Interv Radiol 2012;23:76-9.   DOI
36 Lizaola B, Bonder A, Trivedi HD, Tapper EB, Cardenas A. Review article: the diagnostic approach and current management of chylous ascites. Aliment Pharmacol Ther 2017;46:816-24.   DOI
37 Defize IL, Schurink B, Weijs TJ, et al. The anatomy of the thoracic duct at the level of the diaphragm: a cadaver study. Ann Anat 2018;217:47-53.   DOI
38 Takeuchi H, Miyata H, Gotoh M, et al. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg 2014;260:259-66.   DOI
39 Seow C, Murray L, McKee RF. Surgical pathology is a predictor of outcome in post-operative lymph leakage. Int J Surg 2010;8:636-8.   DOI
40 Johnson OW, Chick JF, Chauhan NR, et al. The thoracic duct: clinical importance, anatomic variation, imaging, and embolization. Eur Radiol 2016;26:2482-93.   DOI
41 Zilversmit DB. The composition and structure of lymph chylomicrons in dog, rat, and man. J Clin Invest 1965;44:1610-22.   DOI
42 Ilczyszyn A, Ridha H, Durrani AJ. Management of chyle leak post neck dissection: a case report and literature review. J Plast Reconstr Aesthet Surg 2011;64:e223-30.   DOI
43 Bach AC, Babayan VK. Medium-chain triglycerides: an update. Am J Clin Nutr 1982;36:950-62.   DOI
44 Lama A, Ferreiro L, Toubes ME, et al. Characteristics of patients with pseudochylothorax: a systematic review. J Thorac Dis 2016;8:2093-101.   DOI
45 Huggins JT. Chylothorax and cholesterol pleural effusion. Semin Respir Crit Care Med 2010;31:743-50.   DOI
46 Agrawal V, Sahn SA. Lipid pleural effusions. Am J Med Sci 2008;335:16-20.   DOI
47 Hillerdal G. Chylothorax and pseudochylothorax. Eur Respir J 1997;10:1157-62.   DOI
48 Merigliano S, Molena D, Ruol A, et al. Chylothorax complicating esophagectomy for cancer: a plea for early thoracic duct ligation. J Thorac Cardiovasc Surg 2000;119:453-7.   DOI
49 Brown S, Abana CO, Hammad H, et al. Low-dose radiation therapy is an effective treatment for refractory postoperative chylous ascites: a case report. Pract Radiat Oncol 2019;9:153-7.   DOI
50 Inaba Y, Arai Y, Matsueda K, Aramaki T, Kodera Y. Intractable massive ascites following radical gastrectomy, treatment with local intraperitoneal administration of OK-432 using a unified CT and fluoroscopy system. Australas Radiol 2003;47:465-7.   DOI
51 Huang Y, Gloviczki P, Duncan AA, et al. Management of refractory chylous ascites with peritoneovenous shunts. J Vasc Surg Venous Lymphat Disord 2017;5:538-46.   DOI
52 Lutz P, Strunk H, Schild HH, Sauerbruch T. Transjugular intrahepatic portosystemic shunt in refractory chylothorax due to liver cirrhosis. World J Gastroenterol 2013;19:1140-2.   DOI
53 Matsutani T, Hirakata A, Nomura T, et al. Transabdominal approach for chylorrhea after esophagectomy by using fluorescence navigation with indocyanine green. Case Rep Surg 2014;2014:464017.
54 Lee YS, Kim BW, Chang HS, Park CS. Factors predisposing to chyle leakage following thyroid cancer surgery without lateral neck dissection. Head Neck 2013;35:1149-52.   DOI
55 Lorenz K, Abuazab M, Sekulla C, Nguyen-Thanh P, Brauckhoff M, Dralle H. Management of lymph fistulas in thyroid surgery. Langenbecks Arch Surg 2010;395:911-7.   DOI
56 Dhiwakar M, Nambi GI, Ramanikanth TV. Drain removal and aspiration to treat low output chylous fistula. Eur Arch Otorhinolaryngol 2014;271:561-5.   DOI
57 Nussenbaum B, Liu JH, Sinard RJ. Systematic management of chyle fistula: the Southwestern experience and review of the literature. Otolaryngol Head Neck Surg 2000;122:31-8.   DOI